Femoral head osteonecrosis after long-term topical corticosteroid treatment in a psoriasis patient.
Hidetoshi
H
Takahashi
Hitomi
H
Tsuji
Masaru
M
Honma
Akemi
A
Ishida-Yamamoto
Hajime
H
Iizuka
D000305:Adrenal Cortex Hormones / Q000009:adverse effects* / Q000097:blood; D000324:Adrenocorticotropic Hormone / Q000097:blood; D019644:Arthroplasty, Replacement, Hip / Q000523:psychology; D002117:Calcitriol / Q000009:adverse effects / Q000031:analogs & derivatives; D002990:Clobetasol / Q000009:adverse effects; D016572:Cyclosporine / Q000009:adverse effects; D003879:Dermatologic Agents / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005270:Femur Head / Q000187:drug effects* / Q000473:pathology* / Q000601:surgery; D006615:Hip / Q000503:physiopathology / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D010020:Osteonecrosis / Q000139:chemically induced* / Q000523:psychology / Q000601:surgery; D011565:Psoriasis / Q000188:drug therapy*; D011788:Quality of Life; D016059:Range of Motion, Articular / Q000187:drug effects; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D003879:Dermatologic Agents; C055085:calcipotriene; D016572:Cyclosporine; D000324:Adrenocorticotropic Hormone; D002990:Clobetasol; D002117:Calcitriol